MDX-1203

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDX-1203, covering 2013-05-22 to 2013-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) [Phase 1]

See pricing